Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 164

Results For "data"

2174 News Found

Lupin engages Flutura to accelerate digitial drive using AI
News | April 21, 2022

Lupin engages Flutura to accelerate digitial drive using AI

Flutura to deploy Cerebra Digital Twin & Pharmacologist Workbench, a self-service AI platform to accelerate impact on Pharmaceutical outcomes


ZEISS announces USFDA clearance of the Quatera 700
Digitisation | April 21, 2022

ZEISS announces USFDA clearance of the Quatera 700

The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise


WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19
News | April 19, 2022

WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19

The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19


Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)
Medical Device | April 19, 2022

Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)

Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey


Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan
Drug Approval | April 19, 2022

Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan

Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies


AI driven Israeli company Embryonics ties-up with Jaslok Hospital
Digitisation | April 19, 2022

AI driven Israeli company Embryonics ties-up with Jaslok Hospital

The data driven fertility company helps increase the success rate of fertility treatments


Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon
Biotech | April 19, 2022

Bridge Biotherapeutics enters into an exclusive license agreement with Shaperon

By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)


PM Narendra Modi lays down five goals for new WHO Global Centre
News | April 19, 2022

PM Narendra Modi lays down five goals for new WHO Global Centre

Jamnagar’s contributions towards wellness will get a global identity with WHO’s Global Centre for Traditional Medicine


PM to inaugurate WHO Global Centre for Traditional Medicine at Jamanagar on April 19
Public Health | April 18, 2022

PM to inaugurate WHO Global Centre for Traditional Medicine at Jamanagar on April 19

The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research


Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis
Healthcare | April 13, 2022

Juniper Biologics acquires cell-mediated gene therapy for treatment of knee osteoarthritis

The US $600 million acquisition will see Juniper Biologics offer the world's first cell-mediated gene therapy to an estimated 300 million patients in Asia Pacific, Middle East and Africa